3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Follicular
1
Cognitive Dysfunction
1
Alzheimer Disease
1
Interventions
fasudil
1
exemestane
1
dalpiciclib
1
citric acid, ispaghula husk, sodium bicarbonate drug combination
1
Vi-siblin
1
Tamoxifen
1
Stents
1
Standard of Care
1
Psyllium
1
Oxaliplatin
1
Mammography
1
Magnetic Resonance Imaging
1
Low-Level Light Therapy
1
Lisaftoclax
1
Leucovorin
1
Laparotomy
1
Laparoscopy
1
Indocyanine Green
1
Immunotherapy
1
Fluorouracil
1
Endoscopy
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Control Groups
1
Capecitabine
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
fasudil
×
30 days
×
Clear all
NCT06362707
2026-05-04
FEAD
Helse Stavanger HF
Phase 2
Recruiting
200 enrolled